- Recent Update of Molecular Targeted Therapy in Pancreatic Cancer
-
Cho JH
- KMID: 1501637
- Korean J Gastroenterol.
- 2013 Mar;61(3):147-154.
- doi: 10.4166/kjg.2013.61.3.147
Pancreatic ductal adenocarcinoma is one of the most dreaded malignancies and the 5th leading cause of cancer-related death in Korea. Late diagnosis and unfavorable response to both chemotherapy and radiotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Serous Retinal Detachment Associated with Choroidal Ischemia with Intravitreal Bevacizumab Following Brain Surgery
-
Cho YJ, Choi EY, Koh HJ, Lee SC, Kim M
- KMID: 2344268
- Korean J Ophthalmol.
- 2014 Oct;28(5):424-426.
- doi: 10.3341/kjo.2014.28.5.424
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Perspectives of the Stomach Cancer Treatment: The Introduction of Molecular Targeted Therapy and the Hope for Cure
-
Cheung DY, Kim JK
- KMID: 1501634
- Korean J Gastroenterol.
- 2013 Mar;61(3):117-127.
- doi: 10.4166/kjg.2013.61.3.117
The overall survival of patients with gastric cancer has increased markedly in Korea, even higher than those of developed nations in Western world. It is due to the virtue of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Perspective: Role of Targeted Therapy in Colon Cancer
-
Chung HH, Jang BI
- KMID: 1501635
- Korean J Gastroenterol.
- 2013 Mar;61(3):128-135.
- doi: 10.4166/kjg.2013.61.3.128
Colorectal cancer is the third most common malignant disease in incidence according to a report in 2009 from Korea. The 5-fluorouracil (5-FU) remains to be a major chemotherapeutic agents. But,... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
-
Chang YS, Han JI, Yoo SJ, Lew YJ, Kim JH
- KMID: 2345823
- Korean J Ophthalmol.
- 2014 Dec;28(6):466-472.
- doi: 10.3341/kjo.2014.28.6.466
PURPOSE: To investigate 12-month treatment outcomes of anti-vascular endothelial growth factor therapy in eyes with typical exudative age-related macular degeneration with good baseline visual acuity. METHODS: This retrospective observational case series... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
-
Wang D, Choi KS, Lee SJ
- KMID: 1792092
- Korean J Ophthalmol.
- 2014 Feb;28(1):32-38.
- doi: 10.3341/kjo.2014.28.1.32
PURPOSE: This study compared serum vascular endothelial growth factor (VEGF) concentration between patients given the bilateral and unilateral intravitreal injections of bevacizumab. METHODS: In a prospective manner, serum VEGF levels in... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined blockade of HER2 and VEGF exerts greater growth inhibition of HER2-overexpressing gastric cancer xenografts than individual blockade
-
Singh R, Kim WJ, Kim PH, Hong HJ
- KMID: 2154271
- Exp Mol Med.
- 2013 Nov;45(11):e52.
Gastric cancer overexpressing the human epidermal growth factor 2 (HER2) protein has a poor outcome, although a combination of chemotherapy and the anti-HER2 antibody trastuzumab has been approved for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
-
Park SU, Lee SJ, Kim M
- KMID: 2344222
- Korean J Ophthalmol.
- 2014 Aug;28(4):306-313.
PURPOSE: To evaluate the efficacy of anti-vascular endothelial growth factor (VEGF) compared with observation for treating acute central serous chorioretinopathy (CSC). METHODS: A retrospective study of 36 patients with acute CSC,... -
- CITED
-
- Close
- SHARE
-
- Close
- Concentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
-
Lim TH, Bae SH, Cho YJ, Lee JH, Kim HK, Sohn YH
- KMID: 1115751
- Korean J Ophthalmol.
- 2009 Sep;23(3):188-192.
- doi: 10.3341/kjo.2009.23.3.188
PURPOSE: To study the concentration of vascular endothelial growth factor (VEGF) in the aqueous humor before and after intracameral injection of bevacizumab in eyes with neovascular glaucoma, and to detect... -
- CITED
-
- Close
- SHARE
-
- Close
- High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
-
Lee DK, Kim SH, You YS, Kwon OW
- KMID: 2373986
- Korean J Ophthalmol.
- 2016 Aug;30(4):265-271.
- doi: 10.3341/kjo.2016.30.4.265
PURPOSE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is the first choice of treatment for age-related macular degeneration. However, quite a few eyes treated using conventional dose anti-VEGF (CDAV) have persistent... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Intravitreal Anti-vascular Endothelial Growth Factor or Steroid Injection in Diabetic Macular Edema According to Fluid Turbidity in Optical Coherence Tomography
-
Lee K, Chung H, Park Y, Sohn J
- KMID: 2344221
- Korean J Ophthalmol.
- 2014 Aug;28(4):298-305.
PURPOSE: To determine if short term effects of intravitreal anti-vascular endothelial growth factor or steroid injection are correlated with fluid turbidity, as detected by spectral domain optical coherence tomography (SD-OCT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Photodynamic Therapy Combined with Intravitreal Bevacizumab in a Patient with Choroidal Neovascularization Secondary to Choroidal Osteoma
-
Jang JH, Kim KH, Lee SJ, Park JM
- KMID: 1499690
- Korean J Ophthalmol.
- 2012 Dec;26(6):478-480.
- doi: 10.3341/kjo.2012.26.6.478
Choroidal osteoma is a benign ossified tumor that is found predominantly in healthy young women during their second and third decades of life. The lesions are white-to-cream or orange in... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas
-
Lee JP, Park JS, Kwon OW, You YS, Kim SH
- KMID: 2373974
- Korean J Ophthalmol.
- 2016 Jun;30(3):192-197.
- doi: 10.3341/kjo.2016.30.3.192
PURPOSE: To evaluate the visual and anatomical outcomes for neovascular age-related macular degeneration with submacular hemorrhage after intravitreal injections of tenecteplase (TNK), anti-vascular endothelial growth factor (VEGF) and expansile gas. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Cytomegalovirus Retinitis after Intravitreal Bevacizumab Injection in an Immunocompetent Patient
-
Bae SH, Kim TW, Chung H, Heo JW
- KMID: 1501800
- Korean J Ophthalmol.
- 2013 Feb;27(1):61-63.
- doi: 10.3341/kjo.2013.27.1.61
We report a case of cytomegalovirus (CMV) retinitis after intravitreal bevacizumab injection. A 61-year-old woman with diabetic macular edema developed dense vitritis and necrotizing retinitis 3 weeks after intravitreal bevacizumab... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Bevacizumab on Bcl-2 Expression and Apoptosis in Retinal Pigment Epithelial Cells under Oxidative Stress
-
Kim S, Kim YJ, Kim NR, Chin HS
- KMID: 2363851
- Korean J Ophthalmol.
- 2015 Dec;29(6):424-432.
- doi: 10.3341/kjo.2015.29.6.424
PURPOSE: To evaluate the effects of bevacizumab on expression of B-cell leukemia/lymphoma (Bcl)-2 and apoptosis in retinal pigment epithelial (RPE) cells under oxidative stress conditions. METHODS: RPE cells were treated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration
-
Lee KH, Chin HS, Kim NR, Moon YS
- KMID: 2363847
- Korean J Ophthalmol.
- 2015 Dec;29(6):396-403.
- doi: 10.3341/kjo.2015.29.6.396
PURPOSE: To investigate the effects of vitreomacular traction (VMT) on ranibizumab treatment response for neovascular age-related macular degeneration (AMD). METHODS: A retrospective review of 85 eyes of 85 patients newly diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Findings of Visual Outcome in Spectral Domain Optical Coherence Tomography after Ranibizumab Treatment in Age-related Macular Degeneration
-
Kwon YH, Lee DK, Kim HE, Kwon OW
- KMID: 2344262
- Korean J Ophthalmol.
- 2014 Oct;28(5):386-392.
- doi: 10.3341/kjo.2014.28.5.386
PURPOSE: To investigate which spectral domain optical coherence tomography (SD-OCT) findings predict visual outcome after anti-vascular endothelial growth factor (VEGF) treatment in neovascular age-related macular degeneration (NV-AMD). METHODS: We reviewed the... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
-
Kim WJ, Jeong HO, Chung SK
- KMID: 949061
- Korean J Ophthalmol.
- 2010 Aug;24(4):230-236.
- doi: 10.3341/kjo.2010.24.4.230
PURPOSE: To determine the efficacy of topical application and subconjunctival injection of bevacizumab in the treatment of corneal neovascularization. METHODS: Corneal neovascularization was induced with a silk suture of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo
-
Kim EC, Kim SH, Piao SJ, Kim TJ, Bae K, Kim HS, Hong SS, Lee BI, Nam M
- KMID: 2164486
- J Korean Med Sci.
- 2015 Jul;30(7):979-987.
- doi: 10.3346/jkms.2015.30.7.979
Angiogenesis, the formation of new blood vessels, is critical for tumor growth and metastasis. Notably, tumors themselves can lead to angiogenesis by inducing vascular endothelial growth factor (VEGF), which is... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery
-
Hwang S, Choi S
- KMID: 2363844
- Korean J Ophthalmol.
- 2015 Dec;29(6):375-381.
- doi: 10.3341/kjo.2015.29.6.375
PURPOSE: To compare the recurrence rates and complications associated with instillation of topical mitomycin C, cyclosporine, and bevacizumab after primary pterygium surgery. METHODS: Between July 2013 and June 2014, we performed... -
- CITED
-
- Close
- SHARE
-
- Close
